Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(+)-4-epi-shikimic acid
-
(-)-4-epi-shikimic acid
-
(1R,4R,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
(1R,4S,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
(1R,6S,10S)-4-benzyloxymethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
(1R,6S,10S)-4-butyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
(1R,6S,10S)-4-cyclopropylmethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
(1R,6S,10S)-4-ethoxymethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
(1R,6S,10S)-4-ethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
(1R,6S,10S)-4-hydroxylmethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
(1R,6S,10S)-6,10-dihydroxy-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
(1R,6S,10S)-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4,7-diene-8-carboxylic acid
(1R,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
(1R,6S,10S)-6,10-dihydroxy-4-propyl-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]prop-2-enenitrile
-
uncompetitive inhibition towards shikimate and competitive inhibition towards ATP
(2E)-3-phenyl-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]prop-2-enamide
-
-
(2E)-N-(3-acetylphenyl)-3-(4-nitrophenyl)prop-2-enamide
-
non-competitive inhibition towards shikimate and competitive inhibition towards ATP
(2E,5Z)-5-[4-(dimethylamino)benzylidene]-2-(2-oxo-2-phenylethylidene)-1,3-thiazolidin-4-one
-
uncompetitive inhibition towards shikimate and competitive inhibition towards ATP
(2R)-N-[3-chloro-4-(methylsulfonyl)benzyl]-2-hydroxy-2-(1-methyl-1H-pyrazol-4-yl)ethanamide
-
-
(3aR,6R,7R,7aS)-6,7-dihydroxy-2,2-dimethyl-3a,6,7,7a-tetrahydro-1,3-benzodioxole-4-carboxylic acid
-
weak competitive reversible inhibitor
(3R,4R,5R)-3,4-dihydroxy-5-(3-methoxybenzyloxy)cyclohex-1-ene-1-carboxylic acid
(3R,4R,5R)-3,4-dihydroxy-5-(3-methylbenzyloxy)cyclohex-1-ene-1-carboxylic acid
(3R,4R,5R)-3,4-dihydroxy-5-(4-methylbenzyloxy)cyclohex-1-ene-1-carboxylic acid
(3R,4R,5R)-3,4-dihydroxy-5-(naphthalen-2-ylmethoxy)cyclohex-1-ene-1-carboxylic acid
(3R,4R,5R)-3,4-dihydroxy-5-(naphthyl-2-yl)methoxycyclohex-1-ene-1-carboxylic acid
(3R,4R,5R)-3,4-dihydroxy-5-[(3-nitrobenzyl)oxy]cyclohex-1-ene-1-carboxylic acid
(3R,4R,5R)-3-amino-4,5-dihydroxycyclohex-1-ene-1-carboxylic acid
-
reversible competitive inhibitor
(3R,4R,5R)-5-(1-benzothiophen-5-ylmethoxy)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
(3R,4R,5R)-5-(3-fluorobenzyloxy)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
(3R,4R,5R)-5-(benzo[b]thiophen-5-yl)methoxy-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
(3R,4R,5R)-5-benzyloxy-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
(3R,4R,5R,6R)-3,4,5,6-tetrahydroxycyclohex-1-ene-1-carboxylic acid
-
weak competitive reversible inhibitor
(3R,4S)-5-(1-benzothiophen-5-yl)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
-
-
(3R,4S,5R)-5-(4-benzyl-1H-1,2,3-triazol-1-yl)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
(3R,4S,5R)-5-(4-phenoxymethyl-1H-1,2,3-triazol-1-yl)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
(3R,4S,5R)-5-bis(3-bromo-1H-indol-5-yl)methylamino-3,4-dihydroxycyclohex-1-eno-1-carboxylic acid
(3S)-3-aminoshikimic acid
(3S,4R,5R)-3-amino-4,5-dihydroxycyclohex-1-ene-1-carboxylic acid
-
reversible competitive inhibitor
(3S,4S,5R)-3,4,5-trihydroxycyclohex-1-ene-1-carboxylic acid
-
-
(4R,7S,8aS)-4-[3-(morpholin-4-yl)-3-oxopropyl]-7-[[4-(trifluoromethoxy)benzyl]amino]hexahydropyrrolo[1,2-a]pyrazin-1(2H)-one
-
-
(4R,7S,8aS)-4-[3-oxo-3-(piperidin-1-yl)propyl]-7-[[4-(trifluoromethoxy)benzyl]amino]hexahydropyrrolo[1,2-a]pyrazin-1(2H)-one
-
-
(NH4)2SO4
-
5 mM, 29% inhibition
1-(2,4-dinitrophenyl)-5-[[(4-fluorophenyl)acetyl]amino]-N-methyl-1H-pyrazole-3-carboxamide
-
IC50 of 0.1 mg/ml
1-(2,4-dinitrophenyl)-N-methyl-5-([[4-(trifluoromethyl)phenyl]acetyl]amino)-1H-pyrazole-3-carboxamide
-
IC50 of 0.05 mg/ml
1-(2,4-dinitrophenyl)-N-methyl-5-[[(4-methylphenyl)acetyl]amino]-1H-pyrazole-3-carboxamide
-
IC50 of 0.05 mg/ml
1-(2,4-dinitrophenyl)-N-methyl-5-[[(4-nitrophenyl)acetyl]amino]-1H-pyrazole-3-carboxamide
-
IC50 of more than 0.1 mg/ml
1-(4-chloro-2,5-dimethoxyphenyl)-1H-tetrazole-5-thiol
inhibitor identified by structure-based virtual screening, docking simulations
1-(5-methoxy-1H-pyrazol-3-yl)-3-[2-[(methylsulfonyl)methyl]benzyl]urea
-
-
1-[(3-ethyl-2,6-dimethylquinolin-4-yl)sulfanyl]methanediamine
inhibitor identified by structure-based virtual screening, docking simulations
1-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-3-propan-2-ylurea
-
-
1-[1-(2-hydroxyethyl)-1H-pyrazol-3-yl]-3-[2-[2-(methylsulfanyl)ethyl]phenyl]urea
-
-
2-(3-methyl-5-sulfanyl-4H-1,2,4-triazol-4-yl)-1-(1,2,3,4-tetrahydro-9H-carbazol-9-yl)ethanone
2-(3-[[(3-cyanobenzyl)carbamoyl]amino]-1H-pyrazol-1-yl)-N-methylacetamide
-
-
2-([[3-([(3R,4S)-4-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]piperidin-3-yl]methyl)-1,2-oxazol-5-yl]methyl]carbamoyl)benzoic acid
-
-
2-[(2Z)-2-(4-nitrobenzylidene)hydrazinyl]-1,3-benzothiazole
-
-
2-[(4-aminophenyl)amino]-3-(piperidin-1-yl)naphthalene-1,4-dione
-
non-competitive inhibition towards shikimate and competitive inhibition towards ATP
2-[(4-chlorophenyl)amino]-N-(5-oxo-4,5-dihydro-1H-pyrazol-3-yl)acetamide
-
-
2-[(6-methyl-4-oxo-3-phenyl-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidin-2-yl)sulfanyl]acetamide
inhibitor identified by structure-based virtual screening, docking simulations
3,5-dichloro-N-[6-(5-hydroxy-3-methyl-1H-pyrazol-1-yl)pyridin-3-yl]benzenesulfonamide
-
-
3-methoxy-4-[2-[2-([2-methoxy-4-[(E)-(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]phenoxy]methyl)phenyl]ethyl]benzaldehyde
-
-
3-methoxy-4-[[2-([2-methoxy-4-[(4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)methyl]phenoxy]methyl)benzyl]oxy]benzaldehyde
-
noncompetitive inhibitor with respect to both shikimate and MgATP
3-phenyl-4-(5-sulfanyl-1H-tetrazol-1-yl)butanoic acid
inhibitor identified by structure-based virtual screening, docking simulations
3-[(5Z)-5-(1,3-benzodioxol-5-ylmethylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]-N-(2-hydroxy-4-nitrophenyl)propanamide
-
-
3-[(8-methoxy-2-methyl-3-propylquinolin-4-yl)sulfanyl]propanoic acid
inhibitor identified by structure-based virtual screening, docking simulations
3-[[difluoro(4-methylphenyl)acetyl]amino]-N,1-dimethyl-1H-pyrazole-5-carboxamide
-
-
4-(5-nitro-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-N-[4-(trifluoromethyl)phenyl]benzene-1-sulfonamide
-
-
4-[(Z)-[1-[2-(1,3-benzothiazol-2-yl)-3-oxo-5-(trifluoromethyl)-2,3-dihydro-1H-pyrazol-4-yl]ethylidene]amino]-N-(4-methylpyrimidin-2-yl)benzene-1-sulfonamide
-
-
4-[(Z)-[2-(1,3-benzothiazol-2-yl)hydrazinylidene]methyl]-2-ethoxyphenyl 3-nitrobenzoate
-
-
5-bromo-2-(5-[(E)-[1-(3,4-dichlorophenyl)-3,5-dioxopyrazolidin-4-ylidene]methyl]furan-2-yl)benzoic acid
-
-
5-bromo-2-(5-[[1-(3,4-dichlorophenyl)-3,5-dioxo-4-pyrazolidinylidene]methyl]-2-furyl)benzoic acid
-
competitive inhibitor toward shikimate and noncompetitive inhibitor with respect to MgATP
5-hydroxy-N-[[(2-oxo-4-phenyl-2H-1-benzopyran-7-yl)oxy]acetyl]-L-tryptophan
-
-
5-[(6S)-5-[[5-(hydroxymethyl)furan-2-yl]methyl]-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-6-yl]-3-[4-(trifluoromethoxy)phenyl]-2H-1,2,4-oxadiazol-1-ium
-
-
5-[[(2-bromo-6-chlorophenyl)acetyl]amino]-N,3-dimethyl-1H-pyrazole-4-carboxamide
-
-
5-[[(4-fluorobenzyl)sulfanyl]methyl]-4-methyl-4H-1,2,4-triazole-3-thiol
inhibitor identified by structure-based virtual screening, docking simulations
5-[[(4-fluorophenyl)acetyl]amino]-N,1-dimethyl-1H-pyrazole-3-carboxamide
-
IC50 of 0.025 mg/ml
5-[[(4-fluorophenyl)acetyl]amino]-N-methyl-1-phenyl-1H-pyrazole-3-carboxamide
-
IC50 of 0.05 mg/ml
5-[[(4-fluorophenyl)acetyl]amino]-N-methyl-1H-pyrazole-3-carboxamide
-
IC50 of 0.05 mg/ml
5-[[(5-chloro-2-hydroxyphenyl)amino]methylidene]-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
6-cyclohexamidomanzamine A
6-deoxymanzamine X
-
noncompetitive inhibition
6-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-5-(3-phenylpropyl)-3a,4,5,6,7,7a-hexahydro-1H-imidazo[4,5-c]pyridine
-
-
8-hydroxymanzamine A
-
noncompetitive inhibition
AMP
-
4 mM, 27% inhibition
caffeic acid
-
1 mM, 44% inhibition
disodium 7-amino-3-[(E)-(5-hydroxy-7-sulfonatonaphthalen-2-yl)diazenyl]naphthalene-2-sulfonate
-
-
ethyl 4-[([(6S)-6-[4-(propan-2-yl)furan-2-yl]-3,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridin-5-yl]carbonyl)amino]benzoate
-
-
manzamine E
-
noncompetitive inhibition
manzamine F
-
noncompetitive inhibition
methyl 4-([[4-methoxy-2-(trifluoromethyl)benzyl]carbamoyl]amino)-1-methyl-1H-pyrazole-5-carboxylate
-
-
methyl 5-([[(5-chloro-2-methoxyphenyl)amino]acetyl]amino)-4-methyl-1H-pyrazole-3-carboxylate
-
-
N,1-dimethyl-5-([[4-(trifluoromethyl)phenyl]acetyl]amino)-1H-pyrazole-3-carboxamide
-
IC50 of 0.05 mg/ml
N,1-dimethyl-5-[[(4-methylphenyl)acetyl]amino]-1H-pyrazole-3-carboxamide
-
IC50 of 0.025 mg/ml
N,1-dimethyl-5-[[(4-nitrophenyl)acetyl]amino]-1H-pyrazole-3-carboxamide
-
IC50 of 0.05 mg/ml
N-(1,3-benzothiazol-2-yl)-6-(methylsulfanyl)-1,3-benzothiazol-2-amine
-
-
N-(2-cyclopropylbenzyl)-1-(2-hydroxyethyl)-1H-pyrazole-4-carboxamide
-
-
N-(3,5-dichloro-4-[[(methylsulfonyl)methyl]amino]phenyl)-5-oxo-4,5-dihydro-1H-pyrazole-3-carboxamide
-
IC50 of 0.025 mg/ml
N-(3-chloro-4-methylphenyl)-2-[(1-methyl-1H-tetrazol-5-yl)sulfanyl]acetamide
inhibitor identified by structure-based virtual screening, docking simulations
N-(4-hydroxyphenyl)-4-[4-oxo-5-[(Z)-2-phenylethenyl]-2-thioxo-1,3-thiazolidin-3-yl]butanamide
-
-
N-(5,7-dimethyl-1,3-benzothiazol-2-yl)-2-methoxybenzamide
-
-
N-methyl-1-phenyl-5-([[4-(trifluoromethyl)phenyl]acetyl]amino)-1H-pyrazole-3-carboxamide
-
IC50 of 0.05 mg/ml
N-methyl-5-([[4-(trifluoromethyl)phenyl]acetyl]amino)-1H-pyrazole-3-carboxamide
-
IC50 of 0.05 mg/ml
N-methyl-5-[[(4-methylphenyl)acetyl]amino]-1-phenyl-1H-pyrazole-3-carboxamide
-
IC50 of 0.025 mg/ml
N-methyl-5-[[(4-methylphenyl)acetyl]amino]-1H-pyrazole-3-carboxamide
-
IC50 of 0.025 mg/ml
N-methyl-5-[[(4-nitrophenyl)acetyl]amino]-1-phenyl-1H-pyrazole-3-carboxamide
-
IC50 of 0.05 mg/ml
N-methyl-5-[[(4-nitrophenyl)acetyl]amino]-1H-pyrazole-3-carboxamide
-
IC50 of 0.1 mg/ml
N-[(2S)-2-[(2-oxo-4-propyl-2H-1-benzopyran-7-yl)oxy]propanoyl]-L-tryptophan
-
-
N-[(2S)-2-[(4-ethyl-2-oxo-2H-1-benzopyran-7-yl)oxy]propanoyl]-5-hydroxy-L-tryptophan
-
-
N-[3,5-dichloro-4-[(methylsulfonyl)amino]phenyl]-5-oxo-4,5-dihydro-1H-pyrazole-3-carboxamide
-
-
N-[5-(2-chlorophenyl)-1,3,4-oxadiazol-2-yl]-3-phenoxybenzamide
-
-
N-[[(6-chloro-2-oxo-4-propyl-2H-1-benzopyran-7-yl)oxy]acetyl]-5-hydroxy-L-tryptophan
-
-
Na2SO4
-
5 mM, 27% inhibition
NaCl
-
250 mM, 50% inhibition
NSC162535
selective inhibitor, identification and binding analysis with enzyme mutant E144A by virtual docking analysis, isothermal titration calorimetry, and crystals structure analysis revealing an induced-fit mechanism, inactivation mechanism, detailed overview. Binding kinetics of wild-type and mutant enzymes
p-coumaric acid
-
1 mM, 14% inhibition
shikimate
substrate inhibition
shikimate 3-phosphate
-
-
sodium (3R,4R,5R)-3,4-dihydroxy-5-((perfluorophenyl)methoxy)-cyclohex-1-ene-1-carboxylate
sodium (3R,4R,5R)-3,4-dihydroxy-5-(3-nitrobenzyloxy)cyclohex-1-ene-1-carboxylate
sodium (3R,4S,5R)-3,4-dihydroxy-5-[[(1H-indol-5-yl)methyl]amino]cyclohex-1-ene-1-carboxylate
sodium (3R,4S,5R)-3,4-dihydroxy-5-[[(naphthalen-2-yl)methyl]amino]cyclohex-1-ene-1-carboxylate
sodium (3R,4S,5R)-5-di(naphth-2-yl)methylamino-3,4-dihydroxycyclohex-1-eno-1-carboxylate
sodium (3R,4S,5R)-5-[bis[(1-benzothiophen-5-yl)methyl]amino]-3,4-dihydroxycyclohex-1-ene-1-carboxylate
sodium (3S,4R,5R)-3-amino-5-(benzo[b]thiophen-5-yl)-methoxy-4-hydroxycyclohex-1-ene-carboxylate
sodium (3S,4S,5R)-3-amino-4-hydroxy-5-(naphth-2-yl)-metoxycyclohex-1-ene-carboxylate
[(4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)sulfanyl]acetic acid
inhibitor identified by structure-based virtual screening, docking simulations
[[1,3-dimethyl-9-(2-methylprop-2-en-1-yl)-2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-8-yl]sulfanyl]acetic acid
inhibitor identified by structure-based virtual screening, docking simulations
[[3-(2-methylprop-2-en-1-yl)-4-oxo-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidin-2-yl]sulfanyl]acetic acid
-
-
(1R,4R,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
-
-
(1R,4R,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
-
(1R,4S,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
-
-
(1R,4S,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
-
(1R,6S,10S)-4-benzyloxymethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
-
(1R,6S,10S)-4-benzyloxymethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
(1R,6S,10S)-4-butyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
-
(1R,6S,10S)-4-butyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
(1R,6S,10S)-4-cyclopropylmethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
-
(1R,6S,10S)-4-cyclopropylmethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
(1R,6S,10S)-4-ethoxymethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
-
(1R,6S,10S)-4-ethoxymethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
(1R,6S,10S)-4-ethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
-
(1R,6S,10S)-4-ethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
(1R,6S,10S)-4-hydroxylmethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
-
(1R,6S,10S)-4-hydroxylmethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
(1R,6S,10S)-6,10-dihydroxy-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
-
-
(1R,6S,10S)-6,10-dihydroxy-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
-
-
(1R,6S,10S)-6,10-dihydroxy-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
-
(1R,6S,10S)-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4,7-diene-8-carboxylic acid
-
-
(1R,6S,10S)-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4,7-diene-8-carboxylic acid
-
-
(1R,6S,10S)-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4,7-diene-8-carboxylic acid
-
(1R,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
-
(1R,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
(1R,6S,10S)-6,10-dihydroxy-4-propyl-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
-
(1R,6S,10S)-6,10-dihydroxy-4-propyl-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
(3R,4R,5R)-3,4-dihydroxy-5-(3-methoxybenzyloxy)cyclohex-1-ene-1-carboxylic acid
-
(3R,4R,5R)-3,4-dihydroxy-5-(3-methoxybenzyloxy)cyclohex-1-ene-1-carboxylic acid
-
(3R,4R,5R)-3,4-dihydroxy-5-(3-methylbenzyloxy)cyclohex-1-ene-1-carboxylic acid
-
(3R,4R,5R)-3,4-dihydroxy-5-(3-methylbenzyloxy)cyclohex-1-ene-1-carboxylic acid
-
(3R,4R,5R)-3,4-dihydroxy-5-(4-methylbenzyloxy)cyclohex-1-ene-1-carboxylic acid
-
(3R,4R,5R)-3,4-dihydroxy-5-(4-methylbenzyloxy)cyclohex-1-ene-1-carboxylic acid
-
(3R,4R,5R)-3,4-dihydroxy-5-(naphthalen-2-ylmethoxy)cyclohex-1-ene-1-carboxylic acid
-
-
(3R,4R,5R)-3,4-dihydroxy-5-(naphthalen-2-ylmethoxy)cyclohex-1-ene-1-carboxylic acid
-
-
(3R,4R,5R)-3,4-dihydroxy-5-(naphthyl-2-yl)methoxycyclohex-1-ene-1-carboxylic acid
-
(3R,4R,5R)-3,4-dihydroxy-5-(naphthyl-2-yl)methoxycyclohex-1-ene-1-carboxylic acid
-
(3R,4R,5R)-3,4-dihydroxy-5-[(3-nitrobenzyl)oxy]cyclohex-1-ene-1-carboxylic acid
-
reversible competitive inhibitor
(3R,4R,5R)-3,4-dihydroxy-5-[(3-nitrobenzyl)oxy]cyclohex-1-ene-1-carboxylic acid
-
reversible competitive inhibitor
(3R,4R,5R)-5-(1-benzothiophen-5-ylmethoxy)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
-
reversible competitive inhibitor
(3R,4R,5R)-5-(1-benzothiophen-5-ylmethoxy)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
-
reversible competitive inhibitor
(3R,4R,5R)-5-(3-fluorobenzyloxy)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
-
(3R,4R,5R)-5-(3-fluorobenzyloxy)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
-
(3R,4R,5R)-5-(benzo[b]thiophen-5-yl)methoxy-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
-
(3R,4R,5R)-5-(benzo[b]thiophen-5-yl)methoxy-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
-
(3R,4R,5R)-5-benzyloxy-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
-
(3R,4R,5R)-5-benzyloxy-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
-
(3R,4S,5R)-5-(4-benzyl-1H-1,2,3-triazol-1-yl)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
-
(3R,4S,5R)-5-(4-benzyl-1H-1,2,3-triazol-1-yl)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
-
(3R,4S,5R)-5-(4-phenoxymethyl-1H-1,2,3-triazol-1-yl)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
-
(3R,4S,5R)-5-(4-phenoxymethyl-1H-1,2,3-triazol-1-yl)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
-
(3R,4S,5R)-5-bis(3-bromo-1H-indol-5-yl)methylamino-3,4-dihydroxycyclohex-1-eno-1-carboxylic acid
-
-
(3R,4S,5R)-5-bis(3-bromo-1H-indol-5-yl)methylamino-3,4-dihydroxycyclohex-1-eno-1-carboxylic acid
-
-
(3S)-3-aminoshikimic acid
competitive reversible inhibitor
(3S)-3-aminoshikimic acid
competitive reversible inhibitor
2-(3-methyl-5-sulfanyl-4H-1,2,4-triazol-4-yl)-1-(1,2,3,4-tetrahydro-9H-carbazol-9-yl)ethanone
inhibitor identified by structure-based virtual screening, docking simulations
2-(3-methyl-5-sulfanyl-4H-1,2,4-triazol-4-yl)-1-(1,2,3,4-tetrahydro-9H-carbazol-9-yl)ethanone
-
-
5-[[(5-chloro-2-hydroxyphenyl)amino]methylidene]-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
-
uncompetitive inhibition towards shikimate and competitive inhibition towards ATP
5-[[(5-chloro-2-hydroxyphenyl)amino]methylidene]-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
-
-
6-cyclohexamidomanzamine A
-
noncompetitive inhibition
6-cyclohexamidomanzamine A
-
-
ADP
-
4 mM, 44% inhibition
ADP
-
0.5 mM; 12% inhibition
manzamine A
-
noncompetitive inhibition
sodium (3R,4R,5R)-3,4-dihydroxy-5-((perfluorophenyl)methoxy)-cyclohex-1-ene-1-carboxylate
-
sodium (3R,4R,5R)-3,4-dihydroxy-5-((perfluorophenyl)methoxy)-cyclohex-1-ene-1-carboxylate
-
sodium (3R,4R,5R)-3,4-dihydroxy-5-(3-nitrobenzyloxy)cyclohex-1-ene-1-carboxylate
-
sodium (3R,4R,5R)-3,4-dihydroxy-5-(3-nitrobenzyloxy)cyclohex-1-ene-1-carboxylate
-
sodium (3R,4S,5R)-3,4-dihydroxy-5-[[(1H-indol-5-yl)methyl]amino]cyclohex-1-ene-1-carboxylate
-
-
sodium (3R,4S,5R)-3,4-dihydroxy-5-[[(1H-indol-5-yl)methyl]amino]cyclohex-1-ene-1-carboxylate
-
-
sodium (3R,4S,5R)-3,4-dihydroxy-5-[[(naphthalen-2-yl)methyl]amino]cyclohex-1-ene-1-carboxylate
-
-
sodium (3R,4S,5R)-3,4-dihydroxy-5-[[(naphthalen-2-yl)methyl]amino]cyclohex-1-ene-1-carboxylate
-
-
sodium (3R,4S,5R)-5-di(naphth-2-yl)methylamino-3,4-dihydroxycyclohex-1-eno-1-carboxylate
-
-
sodium (3R,4S,5R)-5-di(naphth-2-yl)methylamino-3,4-dihydroxycyclohex-1-eno-1-carboxylate
-
-
sodium (3R,4S,5R)-5-[bis[(1-benzothiophen-5-yl)methyl]amino]-3,4-dihydroxycyclohex-1-ene-1-carboxylate
-
-
sodium (3R,4S,5R)-5-[bis[(1-benzothiophen-5-yl)methyl]amino]-3,4-dihydroxycyclohex-1-ene-1-carboxylate
-
-
sodium (3S,4R,5R)-3-amino-5-(benzo[b]thiophen-5-yl)-methoxy-4-hydroxycyclohex-1-ene-carboxylate
-
sodium (3S,4R,5R)-3-amino-5-(benzo[b]thiophen-5-yl)-methoxy-4-hydroxycyclohex-1-ene-carboxylate
-
sodium (3S,4S,5R)-3-amino-4-hydroxy-5-(naphth-2-yl)-metoxycyclohex-1-ene-carboxylate
-
sodium (3S,4S,5R)-3-amino-4-hydroxy-5-(naphth-2-yl)-metoxycyclohex-1-ene-carboxylate
-
additional information
-
no inhibition by shikimate up to 10 mM
-
additional information
-
screening for the dipeptide inhibitor using in silico structure-based design approach, docking analysis, overview
-
additional information
-
molecular docking simulations, Re-docking and cross-docking, and virtual screening for potential inhibitors, analysis of interactions between inhibitors and enzyme residues, overview
-
additional information
-
no inhibition by 1 mM Phe, Tyr, Trp, chorismate or prephenate
-
additional information
-
enzyme structure analysis and modeling for rational drug designing, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.645
(1R,4R,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
at pH 7.7 and 25°C
0.36 - 0.465
(1R,4S,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
0.068 - 0.121
(1R,6S,10S)-4-benzyloxymethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
0.012 - 0.177
(1R,6S,10S)-4-butyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
0.01 - 0.101
(1R,6S,10S)-4-cyclopropylmethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
0.005 - 0.17
(1R,6S,10S)-4-ethoxymethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
0.0155 - 0.041
(1R,6S,10S)-4-ethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
0.038 - 0.333
(1R,6S,10S)-4-hydroxylmethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
0.046 - 0.047
(1R,6S,10S)-6,10-dihydroxy-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
0.062 - 0.104
(1R,6S,10S)-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4,7-diene-8-carboxylic acid
0.028 - 0.0545
(1R,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
0.0092 - 0.072
(1R,6S,10S)-6,10-dihydroxy-4-propyl-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
1.05
(3aR,6R,7R,7aS)-6,7-dihydroxy-2,2-dimethyl-3a,6,7,7a-tetrahydro-1,3-benzodioxole-4-carboxylic acid
-
pH and temperature not specified in the publication
0.001 - 0.135
(3R,4R,5R)-3,4-dihydroxy-5-(3-methoxybenzyloxy)cyclohex-1-ene-1-carboxylic acid
0.0021 - 0.109
(3R,4R,5R)-3,4-dihydroxy-5-(3-methylbenzyloxy)cyclohex-1-ene-1-carboxylic acid
0.0109 - 0.166
(3R,4R,5R)-3,4-dihydroxy-5-(4-methylbenzyloxy)cyclohex-1-ene-1-carboxylic acid
0.0018 - 0.022
(3R,4R,5R)-3,4-dihydroxy-5-(naphthalen-2-ylmethoxy)cyclohex-1-ene-1-carboxylic acid
0.0018 - 0.022
(3R,4R,5R)-3,4-dihydroxy-5-(naphthyl-2-yl)methoxycyclohex-1-ene-1-carboxylic acid
0.062
(3R,4R,5R)-3-amino-4,5-dihydroxycyclohex-1-ene-1-carboxylic acid
-
pH and temperature not specified in the publication
0.00056 - 0.043
(3R,4R,5R)-5-(1-benzothiophen-5-ylmethoxy)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
0.00128 - 0.18
(3R,4R,5R)-5-(3-fluorobenzyloxy)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
0.00056 - 0.043
(3R,4R,5R)-5-(benzo[b]thiophen-5-yl)methoxy-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
0.003 - 0.036
(3R,4R,5R)-5-benzyloxy-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
0.792
(3R,4R,5R,6R)-3,4,5,6-tetrahydroxycyclohex-1-ene-1-carboxylic acid
-
pH and temperature not specified in the publication
0.095 - 2
(3R,4S,5R)-5-(4-benzyl-1H-1,2,3-triazol-1-yl)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
0.067 - 2
(3R,4S,5R)-5-(4-phenoxymethyl-1H-1,2,3-triazol-1-yl)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
0.0082 - 0.0087
(3R,4S,5R)-5-bis(3-bromo-1H-indol-5-yl)methylamino-3,4-dihydroxycyclohex-1-eno-1-carboxylic acid
0.065
(3S,4R,5R)-3-amino-4,5-dihydroxycyclohex-1-ene-1-carboxylic acid
-
pH and temperature not specified in the publication
0.0055
3-methoxy-4-[2-[2-([2-methoxy-4-[(E)-(4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)methyl]phenoxy]methyl)phenyl]ethyl]benzaldehyde
-
pH and temperature not specified in the publication
0.00948
3-methoxy-4-[[2-([2-methoxy-4-[(4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)methyl]phenoxy]methyl)benzyl]oxy]benzaldehyde
0.0064
5-bromo-2-(5-[(E)-[1-(3,4-dichlorophenyl)-3,5-dioxopyrazolidin-4-ylidene]methyl]furan-2-yl)benzoic acid
-
pH and temperature not specified in the publication
0.00219
5-bromo-2-(5-[[1-(3,4-dichlorophenyl)-3,5-dioxo-4-pyrazolidinylidene]methyl]-2-furyl)benzoic acid
0.0024 - 0.0032
6-cyclohexamidomanzamine A
0.012 - 0.021
6-deoxymanzamine X
0.011 - 0.015
8-hydroxymanzamine A
0.000005
asxe1
-
pH and temperature not specified in the publication
0.0049
disodium 7-amino-3-[(E)-(5-hydroxy-7-sulfonatonaphthalen-2-yl)diazenyl]naphthalene-2-sulfonate
-
pH and temperature not specified in the publication
0.058 - 0.063
manzamine E
4.95
shikimate
at pH 7.5 and 25°C
0.041 - 0.71
sodium (3R,4R,5R)-3,4-dihydroxy-5-((perfluorophenyl)methoxy)-cyclohex-1-ene-1-carboxylate
0.00046 - 0.01
sodium (3R,4R,5R)-3,4-dihydroxy-5-(3-nitrobenzyloxy)cyclohex-1-ene-1-carboxylate
0.455 - 2
sodium (3R,4S,5R)-3,4-dihydroxy-5-[[(1H-indol-5-yl)methyl]amino]cyclohex-1-ene-1-carboxylate
0.181 - 2
sodium (3R,4S,5R)-3,4-dihydroxy-5-[[(naphthalen-2-yl)methyl]amino]cyclohex-1-ene-1-carboxylate
0.0003 - 0.048
sodium (3R,4S,5R)-5-di(naphth-2-yl)methylamino-3,4-dihydroxycyclohex-1-eno-1-carboxylate
0.0052 - 0.024
sodium (3R,4S,5R)-5-[bis[(1-benzothiophen-5-yl)methyl]amino]-3,4-dihydroxycyclohex-1-ene-1-carboxylate
0.415 - 0.535
sodium (3S,4R,5R)-3-amino-5-(benzo[b]thiophen-5-yl)-methoxy-4-hydroxycyclohex-1-ene-carboxylate
0.8 - 2
sodium (3S,4S,5R)-3-amino-4-hydroxy-5-(naphth-2-yl)-metoxycyclohex-1-ene-carboxylate
0.36
(1R,4S,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
at pH 7.7 and 25°C
0.465
(1R,4S,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
-
at pH 7.7 and 25°C
0.068
(1R,6S,10S)-4-benzyloxymethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
at pH 7.7 and 25°C
0.121
(1R,6S,10S)-4-benzyloxymethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
at pH 7.7 and 25°C
0.012
(1R,6S,10S)-4-butyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
at pH 7.7 and 25°C
0.177
(1R,6S,10S)-4-butyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
at pH 7.7 and 25°C
0.01
(1R,6S,10S)-4-cyclopropylmethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
at pH 7.7 and 25°C
0.101
(1R,6S,10S)-4-cyclopropylmethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
at pH 7.7 and 25°C
0.005
(1R,6S,10S)-4-ethoxymethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
at pH 7.7 and 25°C
0.17
(1R,6S,10S)-4-ethoxymethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
at pH 7.7 and 25°C
0.0155
(1R,6S,10S)-4-ethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
at pH 7.7 and 25°C
0.041
(1R,6S,10S)-4-ethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
at pH 7.7 and 25°C
0.038
(1R,6S,10S)-4-hydroxylmethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
at pH 7.7 and 25°C
0.333
(1R,6S,10S)-4-hydroxylmethyl-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
at pH 7.7 and 25°C
0.046
(1R,6S,10S)-6,10-dihydroxy-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
at pH 7.7 and 25°C
0.047
(1R,6S,10S)-6,10-dihydroxy-2-oxabicyclo[4.3.1]dec-7-ene-8-carboxylic acid
-
at pH 7.7 and 25°C
0.062
(1R,6S,10S)-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4,7-diene-8-carboxylic acid
at pH 7.7 and 25°C
0.104
(1R,6S,10S)-6,10-dihydroxy-2-oxabicyclo[4.3.1]deca-4,7-diene-8-carboxylic acid
-
at pH 7.7 and 25°C
0.028
(1R,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
at pH 7.7 and 25°C
0.0545
(1R,6S,10S)-6,10-dihydroxy-4-methyl-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
at pH 7.7 and 25°C
0.0092
(1R,6S,10S)-6,10-dihydroxy-4-propyl-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
-
at pH 7.7 and 25°C
0.072
(1R,6S,10S)-6,10-dihydroxy-4-propyl-2-oxabicyclo[4.3.1]deca-4(Z),7-diene-8-carboxylic acid
at pH 7.7 and 25°C
0.001
(3R,4R,5R)-3,4-dihydroxy-5-(3-methoxybenzyloxy)cyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
0.135
(3R,4R,5R)-3,4-dihydroxy-5-(3-methoxybenzyloxy)cyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
0.0021
(3R,4R,5R)-3,4-dihydroxy-5-(3-methylbenzyloxy)cyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
0.109
(3R,4R,5R)-3,4-dihydroxy-5-(3-methylbenzyloxy)cyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
0.0109
(3R,4R,5R)-3,4-dihydroxy-5-(4-methylbenzyloxy)cyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
0.166
(3R,4R,5R)-3,4-dihydroxy-5-(4-methylbenzyloxy)cyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
0.0018
(3R,4R,5R)-3,4-dihydroxy-5-(naphthalen-2-ylmethoxy)cyclohex-1-ene-1-carboxylic acid
-
at pH 7.7 and 25°C
0.022
(3R,4R,5R)-3,4-dihydroxy-5-(naphthalen-2-ylmethoxy)cyclohex-1-ene-1-carboxylic acid
-
at pH 7.7 and 25°C
0.0018
(3R,4R,5R)-3,4-dihydroxy-5-(naphthyl-2-yl)methoxycyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
0.022
(3R,4R,5R)-3,4-dihydroxy-5-(naphthyl-2-yl)methoxycyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
0.00056
(3R,4R,5R)-5-(1-benzothiophen-5-ylmethoxy)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
-
at pH 7.7 and 25°C
0.043
(3R,4R,5R)-5-(1-benzothiophen-5-ylmethoxy)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
-
at pH 7.7 and 25°C
0.00128
(3R,4R,5R)-5-(3-fluorobenzyloxy)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
0.18
(3R,4R,5R)-5-(3-fluorobenzyloxy)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
0.00056
(3R,4R,5R)-5-(benzo[b]thiophen-5-yl)methoxy-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
0.043
(3R,4R,5R)-5-(benzo[b]thiophen-5-yl)methoxy-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
0.003
(3R,4R,5R)-5-benzyloxy-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
0.036
(3R,4R,5R)-5-benzyloxy-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
0.095
(3R,4S,5R)-5-(4-benzyl-1H-1,2,3-triazol-1-yl)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
2
(3R,4S,5R)-5-(4-benzyl-1H-1,2,3-triazol-1-yl)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
Ki above 2.0 mM, at pH 7.7 and 25°C
0.067
(3R,4S,5R)-5-(4-phenoxymethyl-1H-1,2,3-triazol-1-yl)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
at pH 7.7 and 25°C
2
(3R,4S,5R)-5-(4-phenoxymethyl-1H-1,2,3-triazol-1-yl)-3,4-dihydroxycyclohex-1-ene-1-carboxylic acid
Ki above 2.0 mM, at pH 7.7 and 25°C
0.0082
(3R,4S,5R)-5-bis(3-bromo-1H-indol-5-yl)methylamino-3,4-dihydroxycyclohex-1-eno-1-carboxylic acid
-
at pH 7.7 and 25°C
0.0087
(3R,4S,5R)-5-bis(3-bromo-1H-indol-5-yl)methylamino-3,4-dihydroxycyclohex-1-eno-1-carboxylic acid
-
at pH 7.7 and 25°C
0.00948
3-methoxy-4-[[2-([2-methoxy-4-[(4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)methyl]phenoxy]methyl)benzyl]oxy]benzaldehyde
-
pH 8.0, 25°C
0.00948
3-methoxy-4-[[2-([2-methoxy-4-[(4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)methyl]phenoxy]methyl)benzyl]oxy]benzaldehyde
-
in 100 mM TrisHCl (pH 8.0), 50 mM KCl, 5 mM MgCl2, 2 mM ATP, 2 mM phosphoenolpyruvate, 0.7 mM NADH, 3 U/ml proteinase K, 2.5 U/ml lactate dehydrogenase, and 2 mM shikimate, at 25°C
0.00219
5-bromo-2-(5-[[1-(3,4-dichlorophenyl)-3,5-dioxo-4-pyrazolidinylidene]methyl]-2-furyl)benzoic acid
-
pH 8.0, 25°C
0.00219
5-bromo-2-(5-[[1-(3,4-dichlorophenyl)-3,5-dioxo-4-pyrazolidinylidene]methyl]-2-furyl)benzoic acid
-
in 100 mM TrisHCl (pH 8.0), 50 mM KCl, 5 mM MgCl2, 2 mM ATP, 2 mM phosphoenolpyruvate, 0.7 mM NADH, 3 U/ml proteinase K, 2.5 U/ml lactate dehydrogenase, and 2 mM shikimate, at 25°C
0.0024
6-cyclohexamidomanzamine A
-
estimated Ki-value determined with varied shikimate concentrations and a fixed ATP concentration, at pH 7.6 and 25°C
0.0032
6-cyclohexamidomanzamine A
-
estimated Ki-value determined with varied ATP concentrations and a fixed shikimate concentration, at pH 7.6 and 25°C
0.012
6-deoxymanzamine X
-
estimated Ki-value determined with varied shikimate concentrations and a fixed ATP concentration, at pH 7.6 and 25°C
0.021
6-deoxymanzamine X
-
estimated Ki-value determined with varied ATP concentrations and a fixed shikimate concentration, at pH 7.6 and 25°C
0.011
8-hydroxymanzamine A
-
estimated Ki-value determined with varied ATP concentrations and a fixed shikimate concentration, at pH 7.6 and 25°C
0.015
8-hydroxymanzamine A
-
estimated Ki-value determined with varied shikimate concentrations and a fixed ATP concentration, at pH 7.6 and 25°C
0.12
manzamine A
-
estimated Ki-value determined with varied ATP concentrations and a fixed shikimate concentration, at pH 7.6 and 25°C
0.151
manzamine A
-
estimated Ki-value determined with varied shikimate concentrations and a fixed ATP concentration, at pH 7.6 and 25°C
0.058
manzamine E
-
estimated Ki-value determined with varied shikimate concentrations and a fixed ATP concentration, at pH 7.6 and 25°C
0.063
manzamine E
-
estimated Ki-value determined with varied ATP concentrations and a fixed shikimate concentration, at pH 7.6 and 25°C
0.022
manzamine F
-
estimated Ki-value determined with varied shikimate concentrations and a fixed ATP concentration, at pH 7.6 and 25°C
0.04
manzamine F
-
estimated Ki-value determined with varied ATP concentrations and a fixed shikimate concentration, at pH 7.6 and 25°C
0.041
sodium (3R,4R,5R)-3,4-dihydroxy-5-((perfluorophenyl)methoxy)-cyclohex-1-ene-1-carboxylate
at pH 7.7 and 25°C
0.71
sodium (3R,4R,5R)-3,4-dihydroxy-5-((perfluorophenyl)methoxy)-cyclohex-1-ene-1-carboxylate
at pH 7.7 and 25°C
0.00046
sodium (3R,4R,5R)-3,4-dihydroxy-5-(3-nitrobenzyloxy)cyclohex-1-ene-1-carboxylate
at pH 7.7 and 25°C
0.01
sodium (3R,4R,5R)-3,4-dihydroxy-5-(3-nitrobenzyloxy)cyclohex-1-ene-1-carboxylate
at pH 7.7 and 25°C
0.455
sodium (3R,4S,5R)-3,4-dihydroxy-5-[[(1H-indol-5-yl)methyl]amino]cyclohex-1-ene-1-carboxylate
-
at pH 7.7 and 25°C
2
sodium (3R,4S,5R)-3,4-dihydroxy-5-[[(1H-indol-5-yl)methyl]amino]cyclohex-1-ene-1-carboxylate
-
IC50 above 2.0 mM, at pH 7.7 and 25°C
0.181
sodium (3R,4S,5R)-3,4-dihydroxy-5-[[(naphthalen-2-yl)methyl]amino]cyclohex-1-ene-1-carboxylate
-
at pH 7.7 and 25°C
2
sodium (3R,4S,5R)-3,4-dihydroxy-5-[[(naphthalen-2-yl)methyl]amino]cyclohex-1-ene-1-carboxylate
-
IC50 above 2.0 mM, at pH 7.7 and 25°C
0.0003
sodium (3R,4S,5R)-5-di(naphth-2-yl)methylamino-3,4-dihydroxycyclohex-1-eno-1-carboxylate
-
at pH 7.7 and 25°C
0.048
sodium (3R,4S,5R)-5-di(naphth-2-yl)methylamino-3,4-dihydroxycyclohex-1-eno-1-carboxylate
-
at pH 7.7 and 25°C
0.0052
sodium (3R,4S,5R)-5-[bis[(1-benzothiophen-5-yl)methyl]amino]-3,4-dihydroxycyclohex-1-ene-1-carboxylate
-
at pH 7.7 and 25°C
0.024
sodium (3R,4S,5R)-5-[bis[(1-benzothiophen-5-yl)methyl]amino]-3,4-dihydroxycyclohex-1-ene-1-carboxylate
-
at pH 7.7 and 25°C
0.415
sodium (3S,4R,5R)-3-amino-5-(benzo[b]thiophen-5-yl)-methoxy-4-hydroxycyclohex-1-ene-carboxylate
at pH 7.7 and 25°C
0.535
sodium (3S,4R,5R)-3-amino-5-(benzo[b]thiophen-5-yl)-methoxy-4-hydroxycyclohex-1-ene-carboxylate
at pH 7.7 and 25°C
0.8
sodium (3S,4S,5R)-3-amino-4-hydroxy-5-(naphth-2-yl)-metoxycyclohex-1-ene-carboxylate
Ki above 0.8 mM, at pH 7.7 and 25°C
2
sodium (3S,4S,5R)-3-amino-4-hydroxy-5-(naphth-2-yl)-metoxycyclohex-1-ene-carboxylate
Ki above 2.0 mM, at pH 7.7 and 25°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Bode, R.; Birnbaum, D.
Aggregation und Trennbarkeit der Enzyme des Shikimat-Pathway bei Hefen
Z. Allg. Mikrobiol.
21
417-422
1981
Saccharomyces cerevisiae, Meyerozyma guilliermondii, Wickerhamomyces anomalus, Cyberlindnera jadinii, Cyberlindnera fabianii, Ogataea henricii, Lodderomyces elongisporus, Neurospora crassa, Rhodotorula sphaerocarpa, Rhodotorula toruloides, Rhodotorula mucilaginosa, Saccharomycopsis lipolytica
brenda
Lumsden, J.; Coggins, J.R.
The subunit structure of the arom multienzyme complex of Neurospora crassa. A possible pentafunctional polypeptide chain
Biochem. J.
161
599-607
1977
Neurospora crassa
brenda
Oliveira, J.S.; Pinto, C.A.; Basso, L.A.; Santos, D.S.
Cloning and Overexpression in Soluble Form of Functional Shikimate Kinase and 5-Enolpyruvylshikimate 3-Phosphate Synthase Enzymes from Mycobacterium tuberculosis
Protein Expr. Purif.
22
430-435
2001
Mycobacterium tuberculosis
brenda
Morell, H.; Sprinson, D.B.
Shikimate kinase isoenzymes in Salmonella typhimurium
J. Biol. Chem.
243
676-682
1968
Salmonella enterica subsp. enterica serovar Typhimurium
brenda
Koshiba, T.
Alicyclic acid metabolism in plants. 12. Partial purification and some properties of shikimate kinase from Phaseolus mungo seedlings
Plant Cell Physiol.
20
803-809
1979
Vigna mungo
-
brenda
de Feyter, R.
Shikimate kinases from Escherichia coli K12
Methods Enzymol.
142
355-361
1987
Escherichia coli
brenda
Bode, R.; Kunze, G.
Purification and isolation of the arom aggregates of Schizosaccharomyces pombe
Z. Allg. Mikrobiol.
23
289-296
1983
Schizosaccharomyces pombe
brenda
Cerasoli, E.; Kelly, S.M.; Coggins, J.R.; Lapthorn, A.J.; Clarke, D.T.; Price, N.C.
Effects of salts on the function and conformational stability of shikimate kinase
Biochim. Biophys. Acta
1648
43-54
2003
Dickeya chrysanthemi
brenda
Kempner, E.S.; Cole, K.W.; Gaertner, F.H.
The functional unit of the arom conjugate in Neurospora
J. Biol. Chem.
257
8919-8921
1982
Neurospora crassa
brenda
Bowen, J.R.; Kosuge, T.
In vivo activity, purification, and characterization of shikimate kinase from Sorghum
Plant Physiol.
64
382-386
1979
Sorghum bicolor
brenda
DeFeyter, R.C.; Pittard, J.
Purification and properties of shikimate kinase II from Escherichia coli K-12
J. Bacteriol.
165
331-333
1986
Escherichia coli
brenda
Schmidt, C.L.; Daneel, H.J.; Schultz, G.; Buchanan, B.B.
Shikimate kinase from spinach chloroplasts. Purification, characterization and regulatory function in aromatic amino acid biosynthesis
Plant Physiol.
93
758-766
1990
Spinacia oleracea
brenda
Duncan, K.; Edwards, R.M.; Coggins, J.R.
The pentafunctional arom enzyme of Saccharomyces cerevisiae is a mosaic of monofunctional domains
Biochem. J.
246
375-386
1987
Saccharomyces cerevisiae
brenda
Lobner-Olesen, A.; Marinus, M.G.
Identification of the gene (aroK) encoding shikimic acid kinase I of Escherichia coli
J. Bacteriol.
174
525-529
1992
Escherichia coli
brenda
Romanowski, M.J.; Burley, S.K.
Crystal structure of the Escherichia coli shikimate kinase I (AroK) that confers sensitivity to mecillinam
Proteins Struct. Funct. Genet.
47
558-562
2002
Escherichia coli
brenda
Gu, Y.; Reshetnikova, L.; Li, Y.; Wu, Y.; Yan, H.; Singh, S.; Ji, X.
Crystal structure of shikimate kinase from Mycobacterium tuberculosis reveals the dynamic role of the LID domain in catalysis
J. Mol. Biol.
319
779-789
2002
Mycobacterium tuberculosis (P9WPY3), Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv (P9WPY3)
brenda
Krell, T.; Coyle, J.E.; Horsburgh, M.J.; Coggins, J.R.; Lapthorn, A.J.
Crystallization and preliminary X-ray crystallographic analysis of shikimate kinase from Erwinia chrysanthemi
Acta Crystallogr. Sect. D
53
612-614
1997
Dickeya chrysanthemi
brenda
Krell, T.; Coggins, J.R.; Lapthorn, A.J.
The three-dimensional structure of shikimate kinase
J. Mol. Biol.
278
983-997
1998
Dickeya chrysanthemi
brenda
Daugherty, M.; Vonstein, V.; Overbeek, R.; Osterman, A.
Archaeal shikimate kinase, a new member of the GHMP-kinase family
J. Bacteriol.
183
292-300
2001
Methanocaldococcus jannaschii
brenda
Cerasoli, E.; Kelly, S.M.; Coggins, J.R.; Boam, D.J.; Clarke, D.T.; Price, N.C.
The refolding of type II shikimate kinase from Erwinia chrysanthemi after denaturation in urea
Eur. J. Biochem.
269
2124-2132
2002
Dickeya chrysanthemi
brenda
Whipp, M.J.; Pittard, A.J.
A reassessment of the relationship between aroK- and aroL-encoded shikimate kinase enzymes of Escherichia coli
J. Bacteriol.
177
1627-1629
1995
Escherichia coli
brenda
Krell, T.; Maclean, J.; Boam, D.J.; Cooper, A.; Resmini, M.; Brocklehurst, K.; Kelly, S.M.; Price, N.C.; Lapthorn, A.J.; Coggins, J.R.
Biochemical and X-ray crystallographic studies on shikimate kinase: the important structural role of the P-loop lysine
Protein Sci.
10
1137-1149
2001
Dickeya chrysanthemi
brenda
Idziak, C.; Price, N.C.; Kelly, S.M.; Krell, T.; Boam, D.J.; Lapthorn, A.J.; Coggins, J.R.
The interaction of shikimate kinase from Erwinia chrysanthemi with substrates
Biochem. Soc. Trans.
25
S627
1997
Dickeya chrysanthemi
brenda
Pereira, J.H.; de Oliveira, J.S.; Canduri, F.; Dias, M.V.; Palma, M.S.; Basso, L.A.; Santos, D.S.; de Azevedo, W.F., Jr.
Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid
Acta Crystallogr. Sect. D
60
2310-2319
2004
Mycobacterium tuberculosis
brenda
Pereira, J.H.; de Oliveira, J.S.; Canduri, F.; Dias, M.V.; Palma, M.S.; Basso, L.A.; de Azevedo, W.F., Jr.; Santos, D.S.
Interaction of shikimic acid with shikimate kinase
Biochem. Biophys. Res. Commun.
325
10-17
2004
Mycobacterium tuberculosis (P9WPY3), Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv (P9WPY3)
brenda
Dhaliwal, B.; Nichols, C.E.; Ren, J.; Lockyer, M.; Charles, I.; Hawkins, A.R.; Stammers, D.K.
Crystallographic studies of shikimate binding and induced conformational changes in Mycobacterium tuberculosis shikimate kinase
FEBS Lett.
574
49-54
2004
Mycobacterium tuberculosis
brenda
Cheng, W.C.; Chang, Y.N.; Wang, W.C.
Structural basis for shikimate-binding specificity of Helicobacter pylori shikimate kinase
J. Bacteriol.
187
8156-8163
2005
Helicobacter pylori (P56073), Helicobacter pylori
brenda
Kasai, K.; Kanno, T.; Akita, M.; Ikejiri-Kanno, Y.; Wakasa, K.; Tozawa, Y.
Identification of three shikimate kinase genes in rice: characterization of their differential expression during panicle development and of the enzymatic activities of the encoded proteins
Planta
222
438-447
2005
Oryza sativa (Q5NTH3), Oryza sativa (Q5NTH4), Oryza sativa (Q7X7H9), Oryza sativa
brenda
Dias, M.V.; Faim, L.M.; Vasconcelos, I.B.; Simoes de Oliveira, J.; Basso, L.A.; Santos, D.S.; Filgueira de Azevedo, W.J.
Effects of the magnesium and chloride ions and shikimate on the structure of shikimate kinase from Mycobacterium tuberculosis
Acta Crystallogr. Sect. F
F63
1-6
2007
Mycobacterium tuberculosis (P9WPY3), Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv (P9WPY3)
brenda
Gan, J.; Gu, Y.; Li, Y.; Yan, H.; Ji, X.
Crystal structure of Mycobacterium tuberculosis shikimate kinase in complex with shikimic acid and an ATP analogue
Biochemistry
45
8539-8545
2006
Mycobacterium tuberculosis (P9WPY3), Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv (P9WPY3)
brenda
Han, C.; Zhang, J.; Chen, L.; Chen, K.; Shen, X.; Jiang, H.
Discovery of Helicobacter pylori shikimate kinase inhibitors: bioassay and molecular modeling
Bioorg. Med. Chem.
15
656-662
2007
Helicobacter pylori, Helicobacter pylori SS1
brenda
Pereira, J.H.; Vasconcelos, I.B.; Oliveira, J.S.; Caceres, R.A.; de Azevedo, W.F.; Basso, L.A.; Santos, D.S.
Shikimate kinase: a potential target for development of novel antitubercular agents
Curr. Drug Targets
8
459-468
2007
Dickeya chrysanthemi, Escherichia coli, Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv
brenda
Pauli, I.; Caceres, R.A.; de Azevedo, W.F.
Molecular modeling and dynamics studies of shikimate kinase from Bacillus anthracis
Bioorg. Med. Chem.
16
8098-8108
2008
Bacillus anthracis
brenda
Segura-Cabrera, A.; Rodriguez-Perez, M.A.
Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening
Bioorg. Med. Chem. Lett.
18
3152-3157
2008
Mycobacterium tuberculosis (P9WPY3), Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv (P9WPY3)
brenda
Fucile, G.; Falconer, S.; Christendat, D.
Evolutionary diversification of plant shikimate kinase gene duplicates
PLoS Genet.
4
e1000292
2008
Arabidopsis thaliana
brenda
Chen, K.; Dou, J.; Tang, S.; Yang, Y.; Wang, H.; Fang, H.; Zhou, C.
Deletion of the aroK gene is essential for high shikimic acid accumulation through the shikimate pathway in E. coli
Biores. Technol.
119
141-147
2012
Escherichia coli, Escherichia coli DHPYA-T7
brenda
Kenyon, C.P.; Roth, R.L.
The role of the C8 proton of ATP in the catalysis of shikimate kinase and adenylate kinase
BMC Biochem.
13
15
2012
Mycobacterium tuberculosis
brenda
Kumar, M.; Verma, S.; Sharma, S.; Srinivasan, A.; Singh, T.P.; Kaur, P.
Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target shikimate kinase of Mycobacterium tuberculosis
Chem. Biol. Drug Des.
76
277-284
2010
Mycobacterium tuberculosis
brenda
Saidemberg, D.M.; Passarelli, A.W.; Rodrigues, A.V.; Basso, L.A.; Santos, D.S.; Palma, M.S.
Shikimate kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: kinetics and structural dynamics of a potential molecular target for drug development
Curr. Med. Chem.
18
1299-1310
2011
Mycobacterium tuberculosis
brenda
Arora, N.; Banerjee, A.K.; Murty, U.S.
In silico characterization of shikimate kinase of Shigella flexneri: a potential drug target
Interdiscip. Sci.
2
280-290
2010
Shigella flexneri, Shigella flexneri 8401
brenda
Vianna, C.P.; de Azevedo, W.F.
Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations
J. Mol. Model.
18
755-764
2012
Mycobacterium tuberculosis
brenda
Cheng, W.C.; Chen, Y.F.; Wang, H.J.; Hsu, K.C.; Lin, S.C.; Chen, T.J.; Yang, J.M.; Wang, W.C.
Structures of Helicobacter pylori shikimate kinase reveal a selective inhibitor-induced-fit mechanism
PLoS ONE
7
e33481
2012
Helicobacter pylori (P56073), Helicobacter pylori
brenda
Fucile, G.; Garcia, C.; Carlsson, J.; Sunnerhagen, M.; Christendat, D.
Structural and biochemical investigation of two Arabidopsis shikimate kinases: the heat-inducible isoform is thermostable
Protein Sci.
20
1125-1136
2011
Arabidopsis thaliana (Q8GY88), Arabidopsis thaliana
brenda
Sutton, K.A.; Breen, J.; MacDonald, U.; Beanan, J.M.; Olson, R.; Russo, T.A.; Schultz, L.W.; Umland, T.C.
Structure of shikimate kinase, an in vivo essential metabolic enzyme in the nosocomial pathogen Acinetobacter baumannii, in complex with shikimate
Acta Crystallogr. Sect. D
71
1736-1744
2015
Acinetobacter baumannii (A0A0M3KL09), Acinetobacter baumannii, Acinetobacter baumannii 307-0294 (A0A0M3KL09)
brenda
Liu, Z.; Zhu, Q.; Li, Y.; Yu, J.; Wang, W.; Tan, R.; Zhou, J.; Liao, H.
Isolation and in silico characterization of a shikimate kinase from Cassia obtusifolia
Acta Physiol. Plant.
37
85
2015
Senna obtusifolia (A0A0F6PN71)
-
brenda
Simithy, J.; Gill, G.; Wang, Y.; Goodwin, D.C.; Calderon, A.I.
Development of an ESI-LC-MS-based assay for kinetic evaluation of Mycobacterium tuberculosis shikimate kinase activity and inhibition
Anal. Chem.
87
2129-2136
2015
Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv
brenda
Rajput, V.S.; Mehra, R.; Kumar, S.; Nargotra, A.; Singh, P.P.; Khan, I.A.
Screening of antitubercular compound library identifies novel shikimate kinase inhibitors of Mycobacterium tuberculosis
Appl. Microbiol. Biotechnol.
100
5415-5426
2016
Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv
brenda
Prado, V.; Lence, E.; Vallejo, J.A.; Beceiro, A.; Thompson, P.; Hawkins, A.R.; Gonzalez-Bello, C.
Study of the phosphoryl-transfer mechanism of shikimate kinase by NMR spectroscopy
Chemistry
22
2758-2768
2016
Helicobacter pylori (P56073), Helicobacter pylori, Mycobacterium tuberculosis (P9WPY3), Mycobacterium tuberculosis
brenda
Blanco, B.; Prado, V.; Lence, E.; Otero, J.M.; Garcia-Doval, C.; van Raaij, M.J.; Llamas-Saiz, A.L.; Lamb, H.; Hawkins, A.R.; Gonzalez-Bello, C.
Mycobacterium tuberculosis shikimate kinase inhibitors: design and simulation studies of the catalytic turnover
J. Am. Chem. Soc.
135
12366-12376
2013
Mycobacterium tuberculosis (P9WPY3), Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv (P9WPY3)
brenda
Prado, V.; Lence, E.; Maneiro, M.; Vazquez-Ucha, J.C.; Beceiro, A.; Thompson, P.; Hawkins, A.R.; Gonzalez-Bello, C.
Targeting the motion of shikimate kinase: development of competitive inhibitors that stabilize an inactive open conformation of the enzyme
J. Med. Chem.
59
5471-5487
2016
Helicobacter pylori (P56073), Helicobacter pylori, Mycobacterium tuberculosis (P9WPY3), Mycobacterium tuberculosis, Mycobacterium tuberculosis H37Rv (P9WPY3)
brenda
Hsu, K.C.; Cheng, W.C.; Chen, Y.F.; Wang, W.C.; Yang, J.M.
Pathway-based screening strategy for multitarget inhibitors of diverse proteins in metabolic pathways
PLoS Comput. Biol.
9
e1003127
2013
Helicobacter pylori (P56073), Helicobacter pylori
brenda
Rosado, L.A.; Vasconcelos, I.B.; Palma, M.S.; Frappier, V.; Najmanovich, R.J.; Santos, D.S.; Basso, L.A.
The mode of action of recombinant Mycobacterium tuberculosis shikimate kinase: kinetics and thermodynamics analyses
PLoS ONE
8
e61918
2013
Mycobacterium tuberculosis
brenda
Liu, X.; Lin, J.; Hu, H.; Zhou, B.; Zhu, B.
Metabolic engineering of Escherichia coli to enhance shikimic acid production from sorbitol
World J. Microbiol. Biotechnol.
30
2543-2550
2014
Escherichia coli, Escherichia coli JW0379-1
brenda
Simithy, J.; Fuanta, N.R.; Alturki, M.; Hobrath, J.V.; Wahba, A.E.; Pina, I.; Rath, J.; Hamann, M.T.; DeRuiter, J.; Goodwin, D.C.; Calderon, A.I.
Slow-binding inhibition of Mycobacterium tuberculosis shikimate kinase by manzamine alkaloids
Biochemistry
57
4923-4933
2018
Mycobacterium tuberculosis
brenda
Rahul Reddy, M.B.; Krishnasamy, S.K.; Kathiravan, M.K.
Identification of novel scaffold using ligand and structure based approach targeting shikimate kinase
Bioorg. Chem.
102
104083
2020
Mycobacterium tuberculosis
brenda
Prado, V.; Lence, E.; Thompson, P.; Hawkins, A.R.; Gonzalez-Bello, C.
Freezing the dynamic gap for selectivity motion-based design of inhibitors of the shikimate kinase enzyme
Chemistry
22
17988-18000
2016
Helicobacter pylori, Mycobacterium tuberculosis
brenda
Yao, J.; Wang, X.; Luo, H.; Gu, P.
Understanding the catalytic mechanism and the nature of the transition state of an attractive drug-target enzyme (shikimate kinase) by quantum mechanical/molecular mechanical (QM/MM) studies
Chemistry
23
16380-16387
2017
Helicobacter pylori (P56073), Helicobacter pylori
brenda
Gonzalez-Bello, C.
Inhibition of shikimate kinase and type II dehydroquinase for antibiotic discovery Structure-based design and simulation studies
Curr. Top. Med. Chem.
16
960-977
2016
Mycobacterium tuberculosis
brenda
Xu, H.; Zhang, L.; Li, R.; Wang, X.; Liu, S.; Liu, X.; Jing, Y.; Xiao, J.
SKL1 is essential for chloroplast development in Arabidopsis
Front. Plant Sci.
9
179
2018
Arabidopsis thaliana
brenda
Ahmad, S.; Baseer, S.; Navid, A.; Ahmad, F.; Azam, S.
An integrated computational hierarchy for identification of potent inhibitors against shikimate kinase enzyme from Shigella sonnei, a major cause of global dysentery
Gene Rep.
11
283-293
2018
Shigella sonnei
-
brenda
Nugroho, W.S.; Kim, D.W.; Han, J.C.; Hur, Y.B.; Nam, S.W.; Kim, H.J.
Cloning, expression, and characterization of a cold-adapted shikimate kinase from the psychrophilic bacterium Colwellia psychrerythraea 34H
J. Microbiol. Biotechnol.
26
2087-2097
2016
Colwellia psychrerythraea, Escherichia coli (P0A6D7)
brenda
Favela-Candia, A.; Tellez-Valencia, A.; Campos-Almazan, M.; Sierra-Campos, E.; Valdez-Solana, M.; Oria-Hernandez, J.; Castillo-Villanueva, A.; Najera, H.; Avitia-Dominguez, C.
Biochemical, kinetic, and computational structural characterization of shikimate kinase from methicillin-resistant Staphylococcus aureus
Mol. Biotechnol.
61
274-285
2019
Staphylococcus aureus (Q6GGG1), Staphylococcus aureus, Staphylococcus aureus MRSA252 (Q6GGG1), Staphylococcus aureus ATCC BAA1720 (Q6GGG1)
brenda
Pernas, M.; Blanco, B.; Lence, E.; Thompson, P.; Hawkins, A.; Gonzlez-Bello, C.
Synthesis of rigidified shikimic acid derivatives by ring-closing metathesis to imprint inhibitor efficacy against shikimate kinase enzyme
Org. Chem. Front.
6
2514-2528
2019
Helicobacter pylori, Mycobacterium tuberculosis (P9WPY3), Mycobacterium tuberculosis H37Rv (P9WPY3)
-
brenda